




Measurement of Fatigue in Cancer Patients : Suggestions for the Nursing Practice
Received : February. 18,2008






















The purpose of this study was to assess the fatigue in cancer patients measured by unidimensional and
multidimensional scales, and analyze its characteristics based on its relationship to typical symptoms in
an attempt to obtain suggestions for nursing practice. Data were analyzed from self-administered ques-
tionnaires given to 400 inpatients and outpatients with cancer. Fatigue was measured using the CFS
(Cancer Fatigue Scale) and VAS (Visual Analogue Scale), and the following symptoms; fever, nausea,
diarrhea, sleep disorder, pain, dyspnea, loneliness and restlessness, were also assessed. The VAS was also
used to assess anxiety and depression. Data were analyzed using the t-test,  Pearson's correlation coeffi-
cients and chi-square test. The ethical review boards of the participating hospitals approved the study,
which was explained in writing to the patients, who then provided written informed consent to participate.



















































して代表的なものは、日本語版 Piper Fatigue Scale 10）
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Valid data obtained from 338 cancer patients were analyzed. Among  patients with symptoms besides
fatigue, the severity of fatigue was significantly worse when compared to those without other symptoms,
and fatigue were enough to obviously hinder routine activities. Therefore, the control of other symptoms
is important when controlling fatigue in cancer patients. In addition, the correlation between VAS scores
and physical fatigue scores was moderate (r = 0.610), but that between VAS scores and psychological and
cognitive fatigue scores were weak. These findings suggest that the VAS is a convenient instrument for













































































































































































































































































項　　目  人数 ％ 
表 4　症状の有無による倦怠感の比較 n=338
23.64 ± 11.06 
16.67 ± 9.79 
27.10 ± 10.63 
16.50 ± 9.64 
22.45 ± 10.74 
16.59 ± 9.79 
23.28 ± 11.75 
16.64 ± 9.71 
22.85 ± 12.06 
15.58 ± 8.77 
22.39 ± 11.51 
15.52 ± 8.92 
24.48 ± 10.15 
16.03 ± 9.52 
26.75 ± 12.52 
16.65 ± 9.64
4.36 ± 3.23 
3.31 ± 3.00 
6.25 ± 3.48 
3.20 ± 2.90 
4.03 ± 3.25 
3.32 ± 2.99 
4.36 ± 3.04 
3.30 ± 3.01 
4.29 ± 3.35 
3.14 ± 2.88 
4.43 ± 3.48 
3.06 ± 2.79 
5.02 ± 3.43 
3.14 ± 2.88 
5.81 ± 3.82 
3.26 ± 2.93
あり （ 22） 
なし （316） 
あり （ 20） 
なし （318） 
あり （ 31） 
なし （307） 
あり （ 25） 
なし （313） 
あり （ 72） 
なし （266） 
あり （ 79） 
なし （259） 
あり （ 44） 
なし （294） 
あり （ 16） 
なし （322） 
8.09 ± 3.77 
7.58 ± 3.33 
8.70 ± 3.61 
7.55 ± 3.33 
7.71 ± 3.41 
7.61 ± 3.35 
9.44 ± 3.96 
7.47 ± 3.26 
8.60 ± 3.67 
7.35 ± 3.22 
8.37 ± 3.31 
7.39 ± 3.34 
9.11 ± 3.79 
7.39 ± 3.23 
9.50 ± 3.31 
7.52 ± 3.33
 11.18 ± 6.62 
 5.78 ± 5.89 
 12.15 ± 6.72 
 5.75 ± 5.84 
 10.71 ± 6.25 
 5.67 ± 5.87 
 9.48 ± 6.69 
 5.86 ± 5.96 
 9.96 ± 7.54 
 5.09 ± 5.16 
 9.59 ± 6.99 
 5.07 ± 5.35 
 10.34 ± 6.38 
 5.50 ± 5.78 
 11.44 ± 7.41 
 5.87 ± 5.89
45.36 ± 29.73 
24.57 ± 23.94 
46.50 ± 27.30 
24.63 ± 24.14 
43.06 ± 25.13 
24.19 ± 24.18 
44.72 ± 26.53 
24.42 ± 24.12 
38.11 ± 26.50 
22.62 ± 23.35 
36.68 ± 27.11 
22.64 ± 23.18 
39.55 ± 26.31 
23.88 ± 24.00 

















症状 VAS倦怠感  CFS総合的倦怠感  CFS認知的倦怠感  
数値は平均値　± SD 
t検定　*p < 0.05　**p < 0.01
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